Skip to content

Clinical trials

Phase 3 Diabetes Mellitus, Type 2 trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Phase 3 Country / region: United Kingdom Clear all

182 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20015
20024
20034
20049
20057
200614
20073
200815
200916
201021
20114
20129
20138
20147
20154
20166
201710
20182
20196
20203
20221
20233
20242
20253
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed148
Terminated15
Recruiting10
Active, not recruiting7
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S43
AstraZeneca32
Eli Lilly and Company15
Boehringer Ingelheim13
GlaxoSmithKline13
Sanofi13
Hoffmann-La Roche10
Takeda9
Janssen Research & Development, LLC5
Lexicon Pharmaceuticals5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 2182
Diabetes Mellitus64
Obesity12
Glucose Metabolism Disorders10
Overweight10
Cardiovascular Diseases9
Diabetes Mellitus, Type 17
Metabolic Diseases7
Dyslipidemias6
Endocrine System Diseases5

Trials

Showing 1 to 25 of 182. Each trial links to its page on Pharma Observatory.

82 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.